AI Science Tracker
EN

Cross-sectional telomere study and machine-learning analysis in adults with type 2 diabetes after COVID-19

Bogomolets National Medical University; Institute of Gerontology, National Academy of Medical Sciences of Ukraine · 29 Aug 2025 · medicine

Discovery

Cross-sectional telomere study and machine-learning analysis in adults with type 2 diabetes after COVID-19

Source check: Source checked. Not independent scientific confirmation.

Finding: In a cross-sectional pilot of adults with type 2 diabetes, leukocyte telomere length was shorter among those with post-COVID syndrome than those without it. Machine-learning models were also evaluated for identifying syndrome status; this observational association does not establish telomere shortening as a cause.

Technology: Machine-learning classification of post-COVID syndrome using clinical and telomere-related variables.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning classification of post-COVID syndrome using clinical and telomere-related variables.
Test and result
Cross-sectional groups comprised 44 participants with post-COVID syndrome and 22 without; mean telomere length was 1.09±0.19 versus 1.28±0.24 (p=.001); reported gradient-boosting AUC was .753.
Limitation / still unknown
Single-center pilot, cross-sectional association and model evaluation; no causal inference or prospective clinical benefit established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12425890/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.